BCL10 anticorps (AA 122-168)
Aperçu rapide pour BCL10 anticorps (AA 122-168) (ABIN2209252)
Antigène
Voir toutes BCL10 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 122-168
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- BCL10 (B Cell CLL/lymphoma 10, B Cell Leukemia/lymphoma 10, CARD-containing Molecule enhancing NF-kappa-B, CARD-like apoptotic Protein, caspase-recruiting domain-containing Protein, CED-3/ICH-1 Prodomain Homologous E10-like Regulator, Cellular Homolog of vCARMEN, Cellular-E10, cE10, CIPER, hCLAP, mE10, R-RCD1) (BSA & Azide Free)
-
Purification
- Purified by Protein A/G affinity chromatography.
-
Immunogène
- Human BCL10 recombinant protein (epitope aa122-168). Cellular Localization: Nuclear and cytoplasmic
-
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Autre désignation
- BCL10
-
Sujet
- Cellular Localization: Nuclear and cytoplasmic
-
Pathways
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteins
Antigène
-